Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to describe the safety and IOP-lowering efficacy of Travoprost
New Formulations compared to TRAVATAN® and to vehicle in patients with open-angle glaucoma or
ocular hypertension.